Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Information management systems for pharmacogenomics.

Gerhard G Thallinger1, Slave Trajanoski, Gernot Stocker

  • 1Institute of Biomedical Engineering, Graz University of Technology, Krenngasse 37, A-8010 Graz, Austria. zlatko.trajanoski@tugraz.at

Pharmacogenomics
|September 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic inhibition of glutamate-cysteine ligase increases dendritic cell-mediated antitumor immunity in melanoma.

Journal for immunotherapy of cancer·2026
Same author

Coordinated Interferon-γ/Tumor Necrosis Factor axis Drives Selective Loss of Activated Enteric Glia in Inflammatory Bowel Diseases.

Cellular and molecular gastroenterology and hepatology·2026
Same author

IBDome: An Integrated Molecular, Histopathological, and Clinical Atlas of Inflammatory Bowel Diseases.

Gastroenterology·2026
Same author

DUSP1 is a Key Driver of Disease Persistence and Potential Therapeutic Target in Hairy Cell Leukemia.

Blood advances·2026
Same author

Early Gut-Vascular Barrier Breakdown Precedes Colitis Onset in Murine Models.

Cellular and molecular gastroenterology and hepatology·2026
Same author

<i>Escherichia-Shigella</i> expansion and metabolite dysregulation in type 3c diabetes: linking microbiome alterations to exocrine pancreatic insufficiency.

Frontiers in endocrinology·2026
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
Same journal

Practical guide to implementing pre-emptive pharmacogenetic screening in routine pediatric oncology care.

Pharmacogenomics·2026
See all related articles

Integrating patient data with high-throughput genomic research is crucial. Developing robust information management systems is key to effectively capturing and accessing this data for improved clinical interpretation and pharmacogenomic insights.

Area of Science:

  • Genomic Medicine
  • Bioinformatics
  • Clinical Informatics

Background:

  • High-throughput genomic research generates valuable data, but its utility is limited by disparate and unassociated patient information.
  • Current data sources are of varying quality and not readily integrated, hindering comprehensive analysis.
  • Effective interpretation of functional genomic data requires better data management and accessibility.

Purpose of the Study:

  • To review the challenges in managing and analyzing high-throughput genomic and associated clinical data.
  • To highlight current information technology solutions for data integration and accessibility.
  • To propose components for an effective pharmacogenomic data management system.

Main Methods:

  • Review of existing literature on data management in high-throughput genomic research.

Related Experiment Videos

  • Analysis of challenges in integrating disparate clinical and genomic datasets.
  • Identification of essential information technology components for a comprehensive system.

    • Main Results:

    • Significant challenges exist in managing, storing, and analyzing heterogeneous high-throughput data.
    • Current IT solutions are insufficient for seamless integration of clinical and genomic information.
    • A pharmacogenomic data management system requires parallel processing, advanced storage, networking, databases, and application services.

    Conclusions:

    • A robust pharmacogenomic data management system is essential for maximizing the value of genomic research.
    • Integration of public/proprietary databases, clinical datasets, and data mining tools is necessary.
    • The proposed system should leverage high-performance computing infrastructure for efficient data handling and analysis.